Skip to content

Clinical trials

Phase 2 Premature Birth trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Premature Birth Phase: Phase 2 Country / region: United States Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20054
20062
20072
20081
20102
20111
20121
20131
20142
20182
20191
20201
20212
20222
20233
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated6
Recruiting4
Active, not recruiting3
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NICHD Neonatal Research Network3
The University of Texas Health Science Center, Houston2
University of Wisconsin, Madison2
Windtree Therapeutics2
Aerogen Pharma Limited1
Atlantic Health System1
Centers for Disease Control and Prevention1
Children's National Research Institute1
Endeavor Health1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Premature Birth36
Bronchopulmonary Dysplasia8
Enterocolitis, Necrotizing4
Retinopathy of Prematurity4
Respiratory Distress Syndrome3
Anemia2
Brain Injuries2
Ductus Arteriosus, Patent2
Respiratory Distress Syndrome, Newborn2
Abortion, Spontaneous1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.